EVALUATION OF VASCULER ENDOTHELIAL GROWTH FACTOR AS A PROGNOSTIC MARKER IN HEPATOCELLULAR CARCINOMA TREATED BY LOCOREGIONAL THERAPY
Mohamed Esmat Mahmoud Farag;
Abstract
Summary and conclusion
Hepatocellular carcinoma represent the fifth most common malignancy World wide ,and the third most common cause of death from cancer. ( McGlynn KA, London WT, et al. 2005)
AFP remains the most commonly& accepted prognostic b
Hepatocellular carcinoma represent the fifth most common malignancy World wide ,and the third most common cause of death from cancer. ( McGlynn KA, London WT, et al. 2005)
AFP remains the most commonly& accepted prognostic b
Other data
| Title | EVALUATION OF VASCULER ENDOTHELIAL GROWTH FACTOR AS A PROGNOSTIC MARKER IN HEPATOCELLULAR CARCINOMA TREATED BY LOCOREGIONAL THERAPY | Other Titles | دراسة عن تأثيرالعلاج الموضعي لسرطان الكبد على معامل النمو للأنسجة المبطنة للأوعية الدموية | Authors | Mohamed Esmat Mahmoud Farag | Keywords | EVALUATION OF VASCULER ENDOTHELIAL GROWTH FACTOR AS A PROGNOSTIC MARKER IN HEPATOCELLULAR CARCINOMA TREATED BY LOCOREGIONAL THERAPY | Issue Date | 2011 | Description | Summary and conclusion Hepatocellular carcinoma represent the fifth most common malignancy World wide ,and the third most common cause of death from cancer. ( McGlynn KA, London WT, et al. 2005) AFP remains the most commonly& accepted prognostic b |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.